TY  - CHAP
M1  - Book, Section
TI  - Acute Lymphoblastic Leukemia
A1  - Boyiadzis, Michael M.
A1  - Aksentijevich, Ivan
A1  - Litzow, Mark R.
A2  - Boyiadzis, Michael M.
A2  - Fojo, Tito
Y1  - 2022
N1  - 
T2  - Hematology-Oncology Therapy, 3e
AB  - EpidemiologyTable  Graphic  Jump  Location|Download  (.pdf)|PrintEpidemiologyIncidence:6150  (male:  3470;  female:  2680.  Estimated  new  cases  for  2020  in  the  United  States)The  incidence  of  ALL  follows  a  bimodal  distribution,  with  a  peak  between  the  ages  of  2  and  4  years  and  again  during  the  sixth  decadeDeaths:Estimated  1520  in  2020  (male:  860;  female:  660)Median  age:B-cell  lymphoblastic  leukemia/lymphoma:  12  yearsT-cell  lymphoblastic  leukemia/lymphoma:  18  yearsLymphoblastic  leukemia/lymphoma  unknown  lineage:  12  yearsMale  to  female  ratio:1.2:1Dores  GM.  Blood  2012;119:34–43Malard  F  et  al.  Lancet  2020;395:1146–1162Siegel  R  et  al.  CA  Cancer  J  Clin  2020;70:7–30Surveillance,  Epidemiology  and  End  Results  (SEER)  Program,  available  from  http://seer.cancer.gov  [accessed  in  2020]  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - hemonc.mhmedical.com/content.aspx?aid=1187879814
ER  -